A bimodal type of AgPd Plasmonic Blackbody Nanozyme with boosted catalytic efficacy and synergized photothermal therapy for efficacious tumor treatment in the second biological window

Nanozymes are promising for precise cancer treatment, but are typically limited in terms of the low catalytic efficiency and the complexity in tumor microenvironment (TME). Herein, we describe a bimodal type of AgPd plasmonic blackbody (AgPd PB) nanozyme of compact sizes (< 30 nm), which presents...

Descripción completa

Detalles Bibliográficos
Autores principales: Jia, Tao, Li, Dan, Du, Jiarui, Fang, Xikui, Gerasimov, Valeriy, Ågren, Hans, Chen, Guanying
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509650/
https://www.ncbi.nlm.nih.gov/pubmed/36153526
http://dx.doi.org/10.1186/s12951-022-01627-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9509650/
https://www.ncbi.nlm.nih.gov/pubmed/36153526
http://dx.doi.org/10.1186/s12951-022-01627-y

Ejemplares similares